Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Rani Therapeutics LLC currently maintains 4 pending office actions within the Medical Devices & Mechanical Engineering technology area. These 4 actions are distributed among 4 distinct examiners, ensuring that no single examiner oversees more than 1 active matter. This distribution requires the company to manage multiple examination styles simultaneously for its 4 pending office actions.
KOO, BENJAMIN K is the busiest examiner, handling 1 pending office action. With 4 distinct examiners each managing one of the 4 pending office actions, the workload is balanced across the portfolio. The involvement of 3 distinct art units suggests that while the examiners are different, some of the Medical Devices & Mechanical Engineering applications are being reviewed within the same specialized groups. Practitioners should coordinate responses across the 4 distinct examiners to maintain consistency in the Medical Devices & Mechanical Engineering field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOO, BENJAMIN K | 1 | 57.3% | +49.7% |
| CARTER, SANDRA DILLAHUNT | 1 | 56.2% | +28.6% |
| D' AMBROSIO, THEA | 1 | 55.5% | +56.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18810258 | DEVICES, ASSEMBLIES, AND METHODS FOR DELIVERING A FLUID PREPARATION INTO A GASTROINTESTINAL TRACT | KOO, BENJAMIN K | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18810258 | DEVICES, ASSEMBLIES, AND METHODS FOR DELIVERING A FLUID PREPARATION INTO A GASTROINTESTINAL TRACT | KOO, BENJAMIN K | — |
| 18481893 | THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE | CARTER, SANDRA DILLAHUNT | — |
| 18452358 | TREATMENTS FOR HEMOPHILIA A | D' AMBROSIO, THEA | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| 1674 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18810258 | DEVICES, ASSEMBLIES, AND METHODS FOR DELIVERING A FLUID PREPARATION INTO A GASTROINTESTINAL TRACT | KOO, BENJAMIN K | 3783 | §102§103§112 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18481893 | THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE | CARTER, SANDRA DILLAHUNT | 1674 | Other | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18452358 | TREATMENTS FOR HEMOPHILIA A | D' AMBROSIO, THEA | 1654 | §103§112DP | Non-Final OA | — | Pending | Aug 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRani Therapeutics LLC has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Benjamin K Koo has the most, with 1 of Rani Therapeutics LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
